Peter A. Gross M.D., Linda Aho R.N., A.P.N. (Pulmonary Nurse Practitioner), Hormoz Ashtyani M.D. (Director), Jerome Levine M.D. (Director Infectious Disease), Margaret McGee R.N. (Performance Improvement Coordinator), Stephen Moran R.N. (Decision Support Manager), Thomas Anton (Director), Joseph Feldman M.D. (Chairman), Arpi Kuyumjian Pharm.D. (Clinical Pharmacy Coordinator–Infectious Disease Specialist), Joan Skurnick Ph.D. (Project Statistician)
{"title":"Extending the Nurse Practitioner Concurrent Intervention Model to Community-Acquired Pneumonia and Chronic Obstructive Pulmonary Disease","authors":"Peter A. Gross M.D., Linda Aho R.N., A.P.N. (Pulmonary Nurse Practitioner), Hormoz Ashtyani M.D. (Director), Jerome Levine M.D. (Director Infectious Disease), Margaret McGee R.N. (Performance Improvement Coordinator), Stephen Moran R.N. (Decision Support Manager), Thomas Anton (Director), Joseph Feldman M.D. (Chairman), Arpi Kuyumjian Pharm.D. (Clinical Pharmacy Coordinator–Infectious Disease Specialist), Joan Skurnick Ph.D. (Project Statistician)","doi":"10.1016/S1549-3741(04)30043-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>A Nurse Practitioner (NP) Concurrent Intervention Model shown effective for controlling telemetry usage was extended to patients with community-acquired pneumonia (CAP) and patients with chronic obstructive pulmonary disease (COPD).</p></div><div><h3>Methods</h3><p>In spring 2000, investigators at Hackensack University Medical Center and the University of Medicine and Dentistry of New Jersey–New Jersey Medical School began an intervention to increase compliance with the Centers for Medicare & Medicaid Services (CMS) performance measures for CAP. Cost-reduction efforts were introduced by using previously described criteria for switching from intravenous to oral medication and for hospital discharge.</p></div><div><h3>Results</h3><p>Use of the NP intervention model for patients admitted with CAP and for COPD patients resulted in significant reductions in length of stay and cost savings.</p></div><div><h3>Discussion</h3><p>Concurrent intervention by a nurse practitioner can help achieve excellent compliance with performance measures for CAP and be applied to other chronic respiratory diseases such as COPD.</p></div>","PeriodicalId":84970,"journal":{"name":"Joint Commission journal on quality and safety","volume":"30 7","pages":"Pages 377-386"},"PeriodicalIF":0.0000,"publicationDate":"2004-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1549-3741(04)30043-2","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Joint Commission journal on quality and safety","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549374104300432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/11/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15
Abstract
Background
A Nurse Practitioner (NP) Concurrent Intervention Model shown effective for controlling telemetry usage was extended to patients with community-acquired pneumonia (CAP) and patients with chronic obstructive pulmonary disease (COPD).
Methods
In spring 2000, investigators at Hackensack University Medical Center and the University of Medicine and Dentistry of New Jersey–New Jersey Medical School began an intervention to increase compliance with the Centers for Medicare & Medicaid Services (CMS) performance measures for CAP. Cost-reduction efforts were introduced by using previously described criteria for switching from intravenous to oral medication and for hospital discharge.
Results
Use of the NP intervention model for patients admitted with CAP and for COPD patients resulted in significant reductions in length of stay and cost savings.
Discussion
Concurrent intervention by a nurse practitioner can help achieve excellent compliance with performance measures for CAP and be applied to other chronic respiratory diseases such as COPD.